Lack of sodium channel mutation in an Italian family with paramyotonia congenita

Neurology

Volumn 53, Issue 7, 1999, Pages 1549-1555

  Sampaolo, S ^a   Puca, A A ^a   Nigro, V ^a   Cappa, V ^a   Sannino, V ^a   Sanges, G ^a   Bonavita, V ^a   Di Iorio, G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

cDNA analysis; Paramyotonia congenita; SCN4A gene; Sodium channelopathies

Indexed keywords

SODIUM CHANNEL; SODIUM ION;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL ARTICLE; GENE MUTATION; HUMAN; HYPERKALEMIA; MUSCLE STIFFNESS; PEDIGREE ANALYSIS; PERIODIC PARALYSIS; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; THOMSEN DISEASE;

EID: 0032693424     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.7.1549     Document Type: Article

References (22)

1. Rüdel R, Lehmann-Horn F, Ricker K. Altered excitability of the muscle cell membrane. In: Engel AG, Franzini-Armstrong C, eds. Myology. New York: McGraw-Hill, 1994:1291-1334.
2. Cannon SC. From mutation to myotonia in sodium channel disorders. Neuromuscul Disord 1997;7:241-249.
3. Green DS, Hayward LJ, George AL Jr, Cannon SC. A proposed mutation, Val781Ile, associated with hyperkalemic periodic paralysis and cardiac dysrhythmia is a benign polymorphism. Ann Neurol 1997;42:253-256.
4. Lehmann-Horn F, Rüdel R. Hereditary nondystrophic myotonias and periodic paralyses. Curr Opin Neurol 1995;8:402-410.
5. Barchi RL. Molecular pathology of the skeletal muscle sodium channel. Annu Rev Physiol 1995;57:355-385.
6. McClatchey AI, McKenna-Yasek D, Cros D, et al. Novel mutations in families with unusual and variable disorders of the skeletal muscle sodium channel. Nat Genet 1992;2:148-152.
7. Plassart E, Reboul J, Rime CS, et al. Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: phenotype to genotype correlations and demonstration of the predominance of two mutations. Eur J Hum Genet 1994;2: 110-124.
8. Wang J, Zhou J, Todorovic SM, et al. Molecular genetic and genetic correlations in sodium channelopathies: lack of founder effect and evidence for a second gene. Am J Hum Genet 1993;52:1074-1084.
9. Streib EW, Sun SF, Yarkowski T. Transient paresis in myotonic syndromes: a simplified electrophysiologic approach. Muscle Nerve 1982;5:719-723.
10. Kelly P, Yang WS, Costigan D, Farrell MA, Murphy S, Hardiman O. Paramyotonia congenita and hyperkalemic periodic paralysis associated with a Met 1592 Val substitution in the skeletal muscle sodium channel α subunit: a large kindred with a novel phenotype. Neuromuscul Disord 1997;7:105-111.
11. Dubowitz V, ed. Muscle biopsy: a practical approach. 2nd ed. Eastbourne, UK: Baillière Tindall, 1985.
12. Sambrook J, Fritsch EF, Maniatis T, eds. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
13. McClatchey AI, Trofatter J, McKenna-Yasek D, et al. Dinucleotide repeat polymorphisms at the SCN4A locus suggest allelic heterogeneity of hyperkalemic periodic paralysis and paramyotonia congenita. Am J Hum Genet 1992;50:896-901.
14. Nigro V, Politano L, Nigro G, Colonna Romano S, Molinari AM, Puca GA. Detection of a nonsense mutation in the dystrophin gene by multiple SSCP. Hum Mol Genet 1992;1:517-520.
15. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1984;81:3443-3446.
16. Sanger F. Determination of nucleotide sequences in DNA. Science 1981;14:1205-1209.
17. Borg K, Hovmöller M, Larsson L, Edström L. Paramyotonia congenita (Eulenburg): clinical, neurophysiological and muscle biopsy observations in a Swedish family. Acta Neurol Scand 1993;87:37-42.
18. Ptacek LJ, Tawil R, Griggs RC, et al. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology 1994;44:1500-1503.
19. Wagner S, Lerche H, Mitrovic N, Heine R, George AL, Lehmann-Horn F. A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity. Neurology 1997;49:1018-1025.
20. Ptacek LJ, Gouw L, Kwiecinski H, et al. Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis. Ann Neurol 1993;33:300-307.
21. Iles DE, Segers B, Weghuis DO, Seuikerbuijk R, Wicringa B. Localization of the gamma-subunit of the skeletal muscle L-type voltage-dependent calcium channel gene (CACNLG) to human chromosome band 17q24 by in situ hybridization and identification of a polymorphic repetitive DNA sequence at the gene locus. Cytogenet Cell Genet 1993;64:227-230.
22. Elbaz A, Vale-Santos J, Jurkat-Rott K, et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 1995;56: 374-380.